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The emerging field of neuroprosthetics is focused on the development of new therapeutic
interventions that will be able to restore some lost neural function by selective electrical
stimulation or by harnessing activity recorded from populations of neurons. As more
and more patients benefit from these approaches, the interest in neural interfaces
has grown significantly and a new generation of penetrating microelectrode arrays are
providing unprecedented access to the neurons of the central nervous system (CNS).
These microelectrodes have active tip dimensions that are similar in size to neurons and
because they penetrate the nervous system, they provide selective access to these cells
(within a few microns). However, the very long-term viability of chronically implanted
microelectrodes and the capability of recording the same spiking activity over long
time periods still remain to be established and confirmed in human studies. Here we
review the main responses to acute implantation of microelectrode arrays, and emphasize
that it will become essential to control the neural tissue damage induced by these
intracortical microelectrodes in order to achieve the high clinical potentials accompanying
this technology.
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INTRODUCTION
Since 1990, the field of neuroprosthetics has grown at an ever
increasing rate. Although current research is also pursuing non-
invasive techniques to acquire signals from the human brain,
important scientific and clinical information has been gained
from in vivo experiments with microelectrode arrays able to
record or stimulate the nervous system with the aim of improving
or replacing motor or sensory abilities that have been lost due to
disease or injury. For example, auditory brainstem implants are
being used to restore auditory function (Merkus et al., 2014); deep
brain stimulators have been implanted successfully in patients
for control of motor disorders, tremor, dystonia and chronic
pain (Beitz, 2014; Nardone et al., 2014) and micro-array type
devices have been implanted in artificial vision systems (Grill
et al., 2009; Hatsopoulos and Donoghue, 2009; Normann et al.,
2009; Fernandez and Hofmann, 2011). Moreover advances in
prosthetic limbs and brain-machine interfaces are now provid-
ing hope of increased mobility and independence for amputees
and paralyzed patients (Raspopovic et al., 2014) and intracor-
tical micro-electrodes are being used to study epileptiform dis-
charges in cases of intractable epilepsy (Weiss et al., 2013a,b). As
more and more patients have benefited from this approach, the
interest in neural interfaces has grown significantly and a new
generation of penetrating microelectrode arrays are providing
unprecedented access to the neurons of the central nervous system
(CNS).
These studies have shown the utility of microelectrode record-
ings to resolve neural activity at the single neuron level and
to interpret brain derived commands for fine-grained control
of movements and translation of these signals into command
signals that are able to control external devices (Hochberg
et al., 2006; Andersen et al., 2010; Rao and Donoghue, 2014).
However most penetrating microelectrode arrays currently have
maximum in vivo lifetimes from several months to a few
years (Suner et al., 2005; Prasad et al., 2012; Barrese et al.,
2013). Therefore much work still needs to be done before
these penetrating microelectrodes can be used for many clin-
ical purposes. In this work we focused on the acute effects
of implantation of penetrating microelectrode arrays in the
human brain, emphasizing the relevance of surgical techniques
and biocompatibility approaches to control the neural tis-
sue damage induced by these intracortical probes in order
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to achieve the therapeutic benefits envisioned by these neural
interfaces.
CURRENT MULTIELECTRODE-ARRAY TECHNOLOGIES
Technology partially achieved during the development of cardiac
pacemakers has been successfully used in many other applica-
tions of implanted neural prostheses. During these years great
efforts have been made to develop penetrating multi-electrode
arrays with dimensions similar to the cortical neurons they target
for recording or stimulation and that are able to maintain a
stable signal in the CNS. The two main dominant approaches
are multiple insulated metal microwires (Nicolelis and Lebedev,
2009; Freire et al., 2011; Carmena, 2013) and penetrating micro-
electrode arrays fabricated with micro-electro-mechanical-system
technologies. These devices use various substrate materials that
can either be flexible and based on polymers (Rousche et al., 2001;
Chen et al., 2009; Kozai and Kipke, 2009; Hassler et al., 2011) or
rigid such as the Utah Electrode Array (UEA; Normann, 2007),
the Michigan array (Seymour and Kipke, 2007) or the Neuro-
Probes arrays (Neves, 2007; Calixto et al., 2013). However today,
only a few of these devices are commercially available and do
not yet exist as commercial, wireless, implantable, many-channel
devices that can provide reliable recording and stimulation for
many years.
An ideal neural interface would consist of an array containing
many microelectrodes, which can “listen” and “talk” to still-
functioning parts of the brain enabling bi-directional commu-
nication with ensembles of neurons. Each microelectrode would
either record the electrical activity of a small population of neu-
rons surrounding it or, when electrical current is passed through
the electrode, activate small population of neurons. This approach
has been difficult to realize because of the acute and chronic
inflammatory reactions that can induce significant changes at the
brain-electrode interface. Thus all neural probes need a stable
electronic/neural interface that enables selective recording and/or
activation of specific groups of neurons without deterioration
of the electrodes or surrounding neural tissue. Consequently
three areas have to be considered: the “biosafety”, the “biofunc-
tionality” and the “biostability” of the devices. Biosafety means
that the microelectrodes do not harm the brain tissue in any
significant way, biofunctionality is related to the ability of the
microelectrodes to perform their intended function, and biosta-
bility means that the whole microelectrode array must not be
susceptible to attack of biological fluids, proteases, macrophages
or any metabolic byproducts (Marin and Fernandez, 2010).
In addition successful devices should manifest “biotolerabil-
ity” or the ability of the multielectrode-array to reside in the
CNS for long periods of time. All these considerations impose
extreme demands on stability and function of neural implants
and place unique constraints on the architecture, materials,
and surgical techniques used in the application of intracortical
microelectrodes.
SURGICAL PROCEDURES FOR IMPLANTATION OF
INTRACORTICAL MICROELECTRODES ARRAYS
Microelectrode arrays aimed to simultaneously record or stim-
ulate neuronal populations have been successfully used in many
animal models including non-human primates (Normann, 2007).
However the only intracortical microelectrode array that has
been FDA approved for long-term human studies is the UEA
(Nordhausen et al., 1996). This microelectrode array consists of
100 small diameter silicon microneedles, built on a square grid
with 400 µm spacing, that were designed to be inserted into the
cerebral cortex to a depth of 1.5 mm, the level of thalamic input
to the cerebral cortex (Figure 1A).
The UEA has been used in BrainGate clinical trials (Hochberg
et al., 2006; Homer et al., 2013; Perge et al., 2013) and in
research with epilepsy patients (Normann et al., 2009; Truccolo
et al., 2011; Weiss et al., 2013a,b), and we have performed a
number of preliminary experiments designed to establish the
safety of the implantation procedures (House et al., 2006). These
experiments were performed in persons suffering from epilepsy
or brain tumors that had to undergo a surgical resection of
a brain region. Briefly after exposure of the implantation site
using standard neurosurgical equipment and procedures, the pia
arachnoid was cut to allow access to the surface of the cerebral
cortex. Even though the individual electrodes of the UEA are
very sharp (with radius curvatures typically on the order of a few
microns) we found that trying to push 100 electrodes into cortical
tissues only depressed the surface of the tissue and resulted in
only partial insertion of the electrode array. A pneumatically
actuated precision instrument that allows the complete and safe
insertion of the array in under 200 ms was developed to circum-
vent this difficulty (Rousche and Normann, 1992). Interestingly
we found that it was necessary to fine adjust the parameters
of the pneumatic inserter depending of the age of the patients,
and that it was easier to get a complete insertion in young
than in aged patients using low insertion pressures (around 15–
20 psi).
HUMAN ACUTE REACTIVE RESPONSES AROUND
IMPLANTED MICROELECTRODES
Implantation of any neural probe is always a traumatic procedure
that implies some local damage of neurons, vasculature and other
cells (Figures 1C,D). Thus, when a neural probe is inserted into
the brain, some neurons and glial cells are killed or injured
during insertion, blood vessels are disrupted, and the blood-
brain barrier is compromised (Figures 2A,B). As a result, with
most of our microelectrode array insertions in human cortex,
we typically observed interstitial microhemorrhages emanating
from the electrode tracks that extended in one or more directions.
These microhemorrhages were limited to within a few millimeters
of the microelectrode tracks although these were more evident
around the edges of the arrays. This damage seemed to result
from a combination of the numerous blood vessels encountered
in the path of the penetrating electrodes plus some mechani-
cal damage of small capillaries, especially at the borders of the
array. Furthermore although the insertion of the UEA did not
result in clinically relevant hemorrhages, some times we found
petechial hemorrhages located below the tips of the electrodes
(Figures 2C,D).
These microhemorrhages usually stopped spontaneously or
after gentle irrigation with normal saline and we do not have
any case where we had to remove the array due to the bleeding.
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FIGURE 1 | Photographs showing the silicon-based Utah Electrode Array
(UEA) and representative results of its implantation into human cortex.
(A) Scanning electron micrograph of the UEA. (B) Single-unit responses
recorded with the UEA from human temporal cortex (47 superimposed
traces). (C) Astrocytes, labeled here with anti-glial fibrillary acidic protein
antibody (GFAP) increase the thickness of their main processes, especially
around electrode tracks (asterisk). (D) Resident microglial cells and
blood-borne macrophages, labeled here with anti-CD45 antibody, become
activated and migrate toward the electrodes. Note the electrode track filled
with blood cells (asterisk) and a nearby blood vessel. Calibration bars = 50 µm.
However, due to this small bleeding various serum plasma pro-
teins and blood cells stick on the surface of the electrodes and
trigger complement system activation, platelet activation, clot
formation and a large network of changes including the release
of cytokines, invasion of blood-borne macrophages and edema.
Figure 2E shows an example of the tip of an electrode after
explantation. Many red blood cells are seen in close contact with
electrode materials (see Figure 2F). Thus, microhemorrhaging is
an important issue that should be taken into account to reduce
the adverse nature of the reactions and maintain an ideal environ-
ment for the microelectrodes.
Array implantation also causes an early activation and migra-
tion of microglial cells towards the microelectrodes, which could
reflect highly specific interactions mediated by selectins, integrins,
cytokines and carbohydrate-binding receptors (Kaur et al., 2010;
Linnartz et al., 2012). These microglial cells are very sensitive to
pathological conditions, even if they respond only to variations in
local extracellular ionic concentrations (Kreutzberg, 1996; Freire
et al., 2011) and we have found that there is a rapid activation, in a
matter of minutes, of these cells in human brain. Figure 1D shows
an example in an experiment in which the UEA was kept in place
for<10 min.
Usually these scavenger cells form a network of immune
alert resident macrophages with a capacity for immune surveil-
lance and control. Therefore the initial activation and migration
of microglial cells are likely beneficial and include production
of neurotrophic substances and cell adhesion molecules, which
support injured neurons and appear necessary for restorative
events to take place (Eddleston and Mucke, 1993). However, this
largely beneficial initial phase can result in a more adverse long-
term response that is dependent on the extent of the injury.
Consequently more effort is needed to control these responses
and ensure the function of the implant without eliciting either
structural, cellular or metabolic changes that compromise the
microelectrode array performance and/or that result in tissue
degeneration around the implanted microelectrodes.
ELECTROPHYSIOLOGICAL RECORDINGS
As has been shown from experiments in rodents and non-human
primates (Oliveira and Dimitrov, 2008), we found that the quality
of the surgical implantation procedure plays a major role for tissue
preservation and for the outcome of recordings. Our experimen-
tal results have demonstrated that high-quality microelectrode
recordings from cerebral cortical neurons can be consistently
obtained in both acute (intraoperative) and short term chronic
(in an epilepsy monitoring unit) settings. An example of action
potentials recorded with a UEA in the temporal cortex of a patient
with medically intractable epilepsy is shown in Figure 1B. Single
units are easily identifiable with a quality similar to that observed
in rat, cat or non-human primate recordings. Furthermore,
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FIGURE 2 | Gross specimens of human temporal lobe implantations and
scanning micrographs of the surface of the Utah Electrode Array after
acute implantation in human brain. (A) Placement of an electrode array in
temporal cortex. (B) Once the array has been removed there are some
evident microhemorrhages. (C) Horizontal section showing blood in the
outermost electrode tracks and petechial hemorrhages (white arrows) located
below the tip of the electrodes. (D) Detail of the petechial hemorrhages. (E)
Scanning electron micrograph of an electrode tip. Many red blood cells appear
in close contact with electrode materials. (F) Detail of the red blood cells on
the surface of the microelectrodes. Calibration bars A, B, C and D= 2 mm.
most of the presently available intracortical microelectrode arrays
(including the UEA) allow recording of local field potentials
that are very reliable and that can be used to detect changes in
recording quality over time. Also, recording quality is affected by
other surgical procedures: most drugs used for the induction and
maintenance of general anesthesia decrease action potential firing
rates and the information processing capacity in the neocortex
(Hanrahan et al., 2013). In addition local fluctuation in K+
and Ca+ due to acute initial trauma can induce the silencing
of neurons in the proximity of microelectrodes. Consequently
recording sessions are usually initiated between 3–10 days after
implantation.
The ability of intracortical microelectrodes arrays such as
the UEA to record single units from human cortical neurons
demonstrates that the implantation can be done without major
complications, and emphasizes its potential role for studying
encoding and processing of sensory and motor information
by large neuronal ensembles. However significant variations in
spike waveforms across time have been reported (Parker et al.,
2011). These variations could reflect the initial acute response
that can lead to chronic inflammatory reactions. Such reac-
tions can negatively impact neurons and microelectrodes via
induction of glial proliferation that produces a slow progres-
sive decline in spike amplitude and in the number of viable
channels. Furthermore recordings from individual neurons made
with penetrating microelectrodes are often lost but then recover,
possibly because of micro-motion of the device relative to the
neural tissue (Parker et al., 2011). This problem can be miti-
gated with sophisticated action potential identification and daily
recalibration.
CHALLENGES AND FUTURE WORK
Intracortical microelectrode arrays have several advantages over
traditional macroelectrode brain electrophysiological techniques
such as their ability to selectively access individual or small groups
of cortical neurons and the possibility to deliver relevant spatio-
temporal patterns of stimulation. This highlights their potential
to restore some lost neural function through selective electrical
stimulation or by recording activity from selected populations
of neurons. Furthermore the procedures for the implantation of
penetrating microelectrodes are straightforward and well within
the reach of most well-trained neurosurgeons. Altogether these
results suggest that intracortical microelectrodes could form the
basis of new neuroprosthetic devices for treating many disor-
ders of the nervous system. For example they are presently
being used to obtain volitional command signals from primary
motor cortex of people with high cervical spinal injuries or
to provide a limited but useful sense of vision in profoundly
blind. However the presence of acute inflammatory reactions
that can lead to chronic inflammatory reactions affecting both
the neural tissue and the surface of the microelectrodes must
be better understood and new approaches pursued to mitigate
these reactions. Controlling and reducing the neural tissue dam-
age induced by these intracortical microelectrodes should aid in
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keeping these devices biologically and electrically viable for many
years.
Factors affecting brain tissue reactions to intracortical micro-
electrodes include the mechanical trauma during insertion,
implantation method, biological acute responses and the physical
properties of the microelectrodes. Because the brain is so richly
vascularized, we have observed that there is inevitable bleeding
associated with electrode array insertion and this suggests that
bleeding is an important issue that should be taken into account
to reduce the neural tissue damage induced by the microelec-
trodes. Moreover the reliability of recording the same spiking
activity over long time periods still remains an unresolved prob-
lem that must be solved in longer term human studies before
these penetrating microelectrodes can be used for some clinical
purposes.
In this framework, important criteria for clinical success are
tissue and microelectrode preservation and the maintenance of a
stable signal in the CNS for the longest time possible. Remark-
able progress has been reported in the use of these penetrating
microelectrode arrays, but the electrode-tissue interface remains
one of the major obstacles. Intracortical microelectrodes need a
stable electronic/neural interface that facilitates selective record-
ing and/or activation of specific groups of neurons without
damage to the electrodes or surrounding neural tissues. Con-
sequently it is essential to better understand the signals that
lead to neuroglial activation in human brain and to create a
targeted intervention strategy to prevent or at least to control this
response.
Progress in this area relies on scientists being able to inte-
grate and utilize methodologies from disparate disciplines, such
as biomedical engineering, biomaterials, neuroscience, neurol-
ogy, neurosurgery, information and communication technolo-
gies, molecular biology, etc. We are optimistic that with an
emphasis on collaboration and a concerted push for additional
clinical trials, these technologies will form the basis of devices
and therapies that will substantially reduce the burden of lost
neurological functions. However progress will be incremental
and researchers must avoid creating false expectations that could
damage the credibility of these new technologies.
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